Ayataka Fujimoto

Dr. Ayataka Fujimoto

Comprehensive Epilepsy Center, Seirei-Hamamatsu General Hospital, Hamamatsu, Japan
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2019 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
SAStéphane Auvin
Stéphane Auvin
JBJohn J. Bissler
John J. Bissler
Vincent CottinVincent Cottin
Vincent Cottin
Ayataka FujimotoAyataka Fujimoto
Ayataka Fujimoto
Günther F.L. HofbauerGünther F.L. Hofbauer
Günther F.L. Hofbauer
VVVicente Villanueva
Vicente Villanueva
Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder associated with mutations in TSC1 and TSC2 genes, upregulation of mammalian target of rapamycin signaling, and subsequent tumor formation in various organs. Due to the many manifestations of TSC and their potential complications, management requires the expertise of multiple medical disciplines. A multidisciplinary care approach is recommended by consensus guidelines. Use of multidisciplinary teams (MDTs) has been shown to be beneficial in treating other complex diseases, such as cancer. In a lifelong disease such as TSC, an MDT may facilitate the transition from pediatric to adult care. However, little guidance exists in the literature regarding how to organize an MDT in TSC. To discuss the best approach to assembling an MDT, this project was initiated in October 2017 with a meeting of 12 physicians from various specialties and various countries. Following this first meeting, the experts generated statements on the most important aspects to implement in establishing an MDT for TSC by 3 rounds of selection using a Delphi process via electronic correspondence. Finally, TSC patient advocates reviewed the findings and provided additional insights from a patient perspective. A 3-step roadmap was recommended, starting with identifying a single individual to begin organizing care (Step 1), then establishing a small core team (Step 2), and finally, establishing a larger multi-disciplinary team (Step 3). Because of the multisystemic nature of TSC, the MDT should include specialists such as a neurologist, a neurosurgeon, a nephrologist, a urologist, a pulmonologist, an ophthalmologist, a cardiologist, a dermatologist, a geneticist, and a psychiatrist/psychologist. The MDT should recommend a care plan for each patient based on the individual’s needs and in consultation with him/her or his/her family. Some of the most important aspects of an MDT that were agreed upon included identifying a case manager to help coordinate care, providing access to health care professionals of varying specialties, and including a lead physician who takes medical responsibility for patients’ overall care. The results of our consensus provide guidance to support the initiation of an MDT in TSC.

1 November 2018 in Epilepsia Open
Verified
Journal Article
Open access
PDF file
HSHiroshi Shiraku
Hiroshi Shiraku
MNMitsuko Nakashima
Mitsuko Nakashima
STSaoko Takeshita
Saoko Takeshita
CKChai‐Soon Khoo
Chai‐Soon Khoo
MHMuzhirah Haniffa
Muzhirah Haniffa
MKMitsuhiro Kato
Mitsuhiro Kato
Summary: Objective: Vitamin B6–dependent epilepsies are treatable disorders caused by variants in several genes, such as ALDH7A1, PNPO, and others. Recently, biallelic variants in PLPBP, formerly known as PROSC, were identified as a novel cause of vitamin B6–dependent epilepsies. Our objective was to further delineate the phenotype of PLPBP mutation.Methods: We identified 4 unrelated patients harboring a total of 4 variants in PLPBP, including 3 novel variants, in a cohort of 700 patients with developmental and epileptic encephalopathies. Clinical information in each case was collected.Results: Each patient had a different clinical course of epilepsy, with seizure onset from the first day of life to 3 months of age. Generalized tonic–clonic seizures were commonly noted. Myoclonic seizures or focal seizures were also observed in 2 patients. Interictal electroencephalography showed variable findings, such as suppression burst, focal or multifocal discharges, and diffuse slow activity. Unlike previous reports, all the patients had some degree of intellectual disability, although some of them had received early treatment with vitamin B6, suggesting that different mutation types influence the severity and outcome of the seizures.Significance: PLPBP variants should be regarded as among the causative genes of developmental and epileptic encephalopathy, even when it occurs after the neonatal period. Early diagnosis and proper treatment with pyridoxine or pyridoxal phosphate is essential to improve the neurologic prognosis in neonates or young children with poorly controlled seizures.

1 December 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
TOTohru Okanishi
Tohru Okanishi
Ayataka FujimotoAyataka Fujimoto
Ayataka Fujimoto
In 1940, van Wagenen and Herren first proposed the corpus callosotomy (CC) as a surgical procedure for epilepsy. CC has been mainly used to treat drop attacks, which are classified as generalized tonic or atonic seizures. Epileptic spasms (ESs) are a type of epileptic seizure characterized as brief muscle contractions with ictal polyphasic slow waves on an electroencephalogram and a main feature of West syndrome. Resection surgeries, including frontal/posterior disconnections and hemispherotomy, have been established for the treatment of medically intractable ES in patients with unilaterally localized epileptogenic regions. However, CC has also been adopted for ES treatment, with studies involving CC to treat ES having increased since 2010. In those studies, patients without lesions observed on magnetic resonance imaging or equally bilateral lesions predominated, in contrast to studies on resection surgeries. Here, we present a review of relevant literature concerning CC and relevant adaptations. We discuss history and adaptations of CC, and patient selection for epilepsy surgeries due to medically intractable ES, and compared resection surgeries with CC. We propose a surgical selection flow involving resection surgery or CC as first-line treatment for patients with ES who have been assessed as suitable candidates for surgery.

1 January 2018 in Epilepsy & Behavior Case Reports
Verified
Journal Article
Open access
DUDaiki Uchida
Daiki Uchida
Ayataka FujimotoAyataka Fujimoto
Ayataka Fujimoto
TYTomohiro Yamazoe
Tomohiro Yamazoe
TYTakamichi Yamamoto
Takamichi Yamamoto
HEHideo Enoki
Hideo Enoki
A relationship between seizures and intracranial pressure (ICP) has been proposed, but not clearly identified. Whether changes in ICP can evoke seizures remains controversial. We report the case of a 23-year-old man who had undergone shunt surgery in childhood and later presented with focal impaired awareness seizures and behavior arrest. Seizures were uncontrolled despite 3 years of pharmacotherapy, but suddenly stopped after shunt removal. Our case supports the hypothesis that drug-resistant epilepsy can be influenced by changes in ICP. In particular, this case indicates that elevations in ICP may help reduce some seizures.

1 July 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
Ayataka FujimotoAyataka Fujimoto
Ayataka Fujimoto
HEHideo Enoki
Hideo Enoki
KNKeiko Niimi
Keiko Niimi
TNToshiki Nozaki
Toshiki Nozaki
SBShimpei Baba
Shimpei Baba
TOTohru Oanishi
Tohru Oanishi

1 December 2012 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
Ayataka FujimotoAyataka Fujimoto
Ayataka Fujimoto
TYTomohiro Yamazoe
Tomohiro Yamazoe
TYTakuya Yokota
Takuya Yokota
HEHideo Enoki
Hideo Enoki
YSYuki Sasaki
Yuki Sasaki
TYTakamichi Yamamoto
Takamichi Yamamoto